Raleigh Capital Management Inc. Bristol Myers Squibb CO Transaction History
Raleigh Capital Management Inc.
- $229 Million
- Q1 2024
A detailed history of Raleigh Capital Management Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Raleigh Capital Management Inc. holds 26,349 shares of BMY stock, worth $1.06 Million. This represents 0.62% of its overall portfolio holdings.
Number of Shares
26,349
Previous 3,966
564.37%
Holding current value
$1.06 Million
Previous $203,000
603.45%
% of portfolio
0.62%
Previous 0.1%
Shares
10 transactions
Others Institutions Holding BMY
# of Institutions
2,553Shares Held
1.49BCall Options Held
25.9MPut Options Held
20M-
Vanguard Group Inc Valley Forge, PA186MShares$7.45 Billion0.2% of portfolio
-
Black Rock Inc. New York, NY163MShares$6.51 Billion0.21% of portfolio
-
State Street Corp Boston, MA91.6MShares$3.67 Billion0.23% of portfolio
-
Jpmorgan Chase & CO New York, NY88.8MShares$3.56 Billion0.44% of portfolio
-
Capital International Investors Los Angeles, CA70.2MShares$2.81 Billion0.79% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $85.2B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...